Ionis Pharmaceuticals GAAP EPS of -$0.66 beats by $0.55, revenue of $243M beats by $58.62M
- Ionis Pharmaceuticals press release (IONS): Q3 GAAP EPS of -$0.66 beats by $0.55.
- Revenue of $243M (+54.8% Y/Y) beats by $58.62M.
- Revenue in the third quarter and nine months ended September 30, 2026 increased by 55% and 64% respectively, compared to the same periods
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.